Diagnocure, Inc. (DGCRF)
DGCRF Stock Price Chart
Explore Diagnocure, Inc. interactive price chart. Choose custom timeframes to analyze DGCRF price movements and trends.
DGCRF Company Profile
Discover essential business fundamentals and corporate details for Diagnocure, Inc. (DGCRF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
8 Sept 2009
Employees
3.00
Website
https://www.diagnocure.comCEO
Yves Fradet F.R.C.S.,
Description
Diagnocure, Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test. It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services. The company was formerly known as DiagnoCure Inc. 9342-8530 Québec Inc. was founded in 1994 and is headquartered in Quebec, Canada.
DGCRF Financial Timeline
Browse a chronological timeline of Diagnocure, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
DGCRF Stock Performance
Access detailed DGCRF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.